Ibrutinib
janssen,abbvie
['lymsm', 'lymphoma', 'biomarker']
congress #eha22 | gives a talk on ctdna in chl as a prognostic biomarker, its integration with interim pet, and its role in identifying molecular groups with phenotype- and outcome-associated signatures. iosi-ema003 trial, n=215
#lymphoma #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm